MLR-1045

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMLR-1045
Drug Alias Nameoveractive bladder therapy (Melior)irritable bowel syndrome therapy (Melior)MLR-1045
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUrinary Bladder, OveractiveIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMelior Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMelior Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsUrinary Bladder, OveractiveIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A